Skip to content

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (CFS)

BASICS

Description

  • Chronic, complex illness with new/prolonged, debilitating fatigue (>6 months, moderate/severe at least half the time)
  • Marked reduction in activity, not explained by another medical condition
  • Key features: impaired memory/concentration, joint/muscle pain, nonrestorative sleep, postexertional malaise (PEM), orthostatic intolerance
  • Synonyms: myalgic encephalomyelitis (ME), postviral fatigue syndrome, chronic Epstein-Barr virus syndrome, chronic fatigue immune dysfunction, systemic exertion intolerance disease

EPIDEMIOLOGY

  • All ages; peaks: 10–19 & 30–39 years
  • Females 2× as likely
  • Prevalence: 519–1,038/100,000; 1.7–3.4 million U.S. cases
  • Up to 90% undiagnosed

ETIOLOGY & PATHOPHYSIOLOGY

  • Cause unknown, likely multifactorial
  • Suspected stressors: viral/bacterial/parasitic infection (e.g., EBV, Lyme, HHV6), recent vaccination, overexertion, sleep deprivation, toxins, trauma, adverse medication reaction
  • Contributing factors:
  • Cellular metabolism: ↓ oxidative phosphorylation/mitochondrial function (T cells)
  • Neuroendocrine: ↓ cortisol response
  • Immune: ↑ cytokines, CRP, β2-microglobulin
  • Muscular: ↓ oxygen uptake
  • Autonomic: orthostatic hypotension
  • Serotonergic: upregulated serotonin receptors
  • GI: ↑ permeability, altered microbiota, IBS
  • Genetics: higher concordance in monozygotic twins; polymorphisms in neuroimmunoendocrine genes

RISK FACTORS

  • Family history
  • Personality: neuroticism, introversion
  • Comorbidities: depression, anxiety, childhood trauma, inactivity/overactivity, long-standing medical/mental health issues
  • Prolonged idiopathic chronic fatigue

ASSOCIATED CONDITIONS

  • Fibromyalgia, IBS, pelvic pain, endometriosis, gynecologic surgery
  • Anxiety, depression, PTSD, ADHD
  • POTS, OSA, migraines, TMJ, interstitial cystitis, Hashimoto, Raynaud, allergies
  • Multiple chemical sensitivities, myofascial pain, reduced LV size/mass, mitral valve prolapse

DIAGNOSIS

History

  • IOM 2015 Criteria:
  • Substantial reduction in activity ≥6 months with profound, new fatigue not alleviated by rest
  • PEM: worsening after exertion
  • Nonrestorative sleep
  • At least one: cognitive impairment or orthostatic intolerance

Physical Exam

  • Rule out other causes (medical, mental status)

Differential Diagnosis

  • Idiopathic chronic fatigue, depression, anxiety, substance use
  • Poor sleep hygiene, pregnancy, menopause
  • Sleep, endocrine, chronic/acute infection, medication, toxin, rheumatologic, inflammatory, neurologic, cardiovascular, malignancy

Diagnostic Tests

  • No specific test; screen to exclude other causes
  • Initial labs: CBC, CMP, UA, TSH, free T4, ESR/CRP, Mg, Phos, B12, folate, CK, Vit D, iron studies
  • Follow-up: ANA, RF, TST, salivary cortisol, HIV, RPR, Lyme, TTG IgA, drug screen, age/gender-appropriate cancer screening, EEG/MRI (if CNS symptoms), polysomnography (if sleep disorder suspected)

TREATMENT

General Measures

  • Symptom control and guided self-management
  • Address most troublesome symptoms (pain, insomnia)
  • CBT: not curative, but may improve coping/rehab
  • GET: gradual increase, only with trained professional; pacing to manage PEM
  • Multidisciplinary approach

Medication

  • No established drugs for CFS
  • Symptom-based: nonaddicting sleep aids (hydroxyzine, trazodone, doxepin); agomelatine promising; antivirals, antidepressants, immunoglobulins, steroids, modafinil, methylphenidate, gabapentin, galantamine—no clear benefit
  • Use lowest effective dose

Referral

  • Psychiatry (behavioral), rehabilitation, sleep/pain specialists

Complementary & Alternative

  • Acupuncture, massage, chiropractic, PT, stretching, hydrotherapy, yoga, tai chi, qigong, meditation
  • Hot/cold packs, warm baths, electrical massagers, TENS
  • Homeopathy/biofeedback: equivocal evidence

ONGOING CARE

Monitoring

  • No consensus; periodic reevaluation/support
  • Diet: no evidence for any particular diet

Patient Education

  • Gradually increase exercise tolerance
  • Explain PEM/energy envelope; teach “paced” activity
  • Avoid extended rest, but ensure adequate breaks
  • CBT, lifestyle, pharmacologic options
  • Educate family, support disability applications
  • Patient resources: Solve ME/CFS, CDC ME/CFS

PROGNOSIS

  • Severity: mild, moderate, severe, very severe
  • Fluctuating course, relapses common, improvement slow (months–years)
  • <1/3 return to work; 25% bedridden/housebound

COMPLICATIONS

  • Activity reduction, depression, polypharmacy
  • Unemployment/secondary gain
  • ↑ Non-Hodgkin lymphoma risk in elderly with chronic immune activation

ICD-10

  • R53.82: Chronic fatigue, unspecified

Clinical Pearls

  • IOM criteria for diagnosis
  • True CFS is less common than idiopathic chronic fatigue
  • No pharmacologic agent consistently effective
  • Management: symptom relief, QoL, patient support, needs assessment